News MS Study Questions Safety of Bacteria Commonly Used as Vaccine Adjuvant MS Study Questions Safety of Bacteria Commonly Used as Vaccine Adjuvant by Patricia Inacio, PhD | January 12, 2016 Share this article: Share article via email Copy article link In a recent study, a team of researchers argued that, contrary to what has been proposed, subclinical Bordetella pertussis colonization is an important cause of multiple sclerosis (MS). The study, “The potential role of subclinical Bordetella Pertussis colonization in the etiology of multiple sclerosis,” was published in the journal Immunobiology. The bacteria Bordetella pertussis and its secreted toxin have been extensively used within the last 50 years as a potent adjuvant, or substance added to a vaccine to increase the body’s immune response to it. When co-administered with neural antigens, the bacteria induces neuropathology in experimental autoimmune encephalomyelitis, the key animal model for human MS. Researchers now hypothesize that subclinical Bordetella pertussis nasopharyngeal colonization is not innocuous to hosts, and can actually behave as a human neuropathogen causing MS. The team reviewed three epidemiological cases that offer evidence supporting their hypothesis. The first is the major MS-related epidemiologic phenomenon of the last century — the MS epidemic in the Faroe Islands during and immediately after World War II. According to the article, authors who studied the outbreak noted that “MS is the rare late outcome of a specific but unknown infectious disease of adolescence and young adulthood.” The second evidence comes from epidemiological studies establishing that the world’s MS burden exhibits an equatorial gradient, so that the further a person moves from the equator, the greater is that person’s MS risk. Researchers propose that the heterogeneous global risks for MS parallel heterogeneous global Bordetella pertussis vaccination rates. Finally, the third epidemiological case is U.S. government data indicating increased MS mortality among elementary and secondary school teachers (when compared with all other professional occupations), suggesting an increased risk for symptomatic and asymptomatic Bordetella pertussis infection. Researchers concluded that these epidemiological cases indeed suggest there is a substantial probable cause for subclinical Bordetella pertussis colonization as a cause of MS. Since Bordetella pertussis is a frequent colonizer of the human nasopharynx, particularly in highly vaccinated populations, the team suggested that studies are warranted to investigate further MS development as a result of Bordetella pertussis colonization. Print This Page About the Author Patricia Inacio, PhD Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship. Tags experimental autoimmune encephalomyelitis
April 23, 2024 News by Margarida Maia, PhD AAN 2024: Subcutaneous Ocrevus led to nearly no relapses after year
April 22, 2024 News by Margarida Maia, PhD Viatris launches low-dose Copaxone generic formulation in Canada